TNFSF11 and inflammatory bowel disease: Narayanan et al. (2018) found paralleled upregulated level of TNF-α and RANKL in gut and bone and thereby developed a novel holistic therapeutic approach dependent on the decrease of TNF-α and RANKL, suggesting the importance of paying attention to the change of immune microenvironment in bone in IBD treatment.